Ingen Technologies, Inc.
IGNT
OTC Markets US Pink Slips0.00
USD
+0.00
- -
Ingen Technologies, Inc.
IGNT
(OTC Markets US Pink Slips)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Ingen Technologies, Inc. (IGNT) engages in the research, development, and manufacturing of home healthcare products for the respiratory market, primarily targeting patients with chronic obstructive pulmonary disease (COPD). The company offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademarks, which accurately measure flow rates and confirm oxygen delivery; these Class-I FDA-registered devices hold Medicare reimbursement approval via HCPCS code and are distributed through national and international networks for home, hospital, aviation, automotive, emergency response, military, and government applications. Founded in 1999 and headquartered at 3410 La Sierra Avenue, Suite F 507, Riverside, California, Ingen operates in the United States with a wholly owned subsidiary focused on medical device production under a California Department of Public Health manufacturing license. In recent years, the company has explored acquisition opportunities and strategic partnerships, including a 2009 agreement to engage an investment banker for potential buyouts by larger medical firms following debt reduction and anticipated profitability, alongside funding secured for the ATMC acquisition completion and business expansion auditing. No major updates, new product launches, funding rounds, or operational shifts are reported in 2024 or 2025.
Brainsway (NASDAQ:BWAY) vs. Ingen Technologies (OTCMKTS:IGNT) Head to Head Review